Treatment with sulforaphane potentiates the proapoptotic effect of temozolomide (TMZ) on glioma cells by enhancing the activity of caspase-3 and -7 and the expression of Bax, by lowering the levels of miR-21 through Wnt/β-catenin signaling [115]. This evidence concerns the gene BAX and central nervous system cancer.